Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study.
Yoo Ri ChungKyoung Hwa HaHyeon Chang KimSang Jun ParkKihwang LeeDae-Jung KimPublished in: Diabetes & metabolism journal (2019)
This population-based cohort study showed that the use of DPP4i as add-on therapy to metformin did not increase the risk of DR progression compared to SU.